Testing effectiveness (Phase 2)Not Yet RecruitingNCT07268521
What this trial is testing
Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab
Who this might be right for
Cryoglobulinemic Vasculitis (CV)
Assistance Publique - Hôpitaux de Paris 30